TOP NEWS

Ionis Pharmaceuticals Gets $28M From AstraZeneca

Carlsbad-based biopharmaceutical sdeveloper Ionis Pharmaceuticals said Friday that it has received $28M from AstraZeneca, folloing the completion of IND studies and licensing of an antisense drug for treating cancer. The company said that it is eligible to receive up to $137M more in additional development and regulatory milestone payments from AstraZenca associated with its drug, along with "low double digit" royalties from sales of the drug.


LATEST HEADLINES

More Headlines

BROWSE ISSUES